跳至主要内容
临床试验/NCT03662646
NCT03662646已完成不适用

Clock Gene Disruption May be an Initial Manifestation of IBD and Celiac .

Tel-Aviv Sourasky Medical Center1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年8月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
clock gene expression levels in intestinal mucosal samples and WBC peripheral blood.

研究概览

简要总结

patients 6-25 years old upon diagnostic evaluation will be recruited . study population will comprise of two groups: newly diagnosed IBD patients/ Celiac disease and healthy controls.

upon enrollment, subjects will fill out sleeping habits questioners, demographic data, medical history.

blood samples will be drawn for CRP and clock gene expression in systemic WBC. intestinal biopsies will be snap frozen for clock gene extraction and amplification only for patients with IBD.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
6 Years 至 25 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • IBD or celiac patients with a confirmed diagnosis, recruited upon diagnosis.
  • Both male and female
  • Age 6-25 years
  • Medically treated for IBD in our institute.

排除标准

  • Genetic disorder.
  • Known primary or secondary immunodeficiency .
  • Pregnancy or lactating

结局指标

主要结局

clock gene expression levels in intestinal mucosal samples and WBC peripheral blood.

时间窗: 4 years

PCR amplification levels

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Eli Sprecher, MD

Dr. Yael Weintraub, Prof. Shlomi Cohen

Tel-Aviv Sourasky Medical Center

研究点 (1)

Loading locations...

相似试验